Physician profile
Robert Greenleaf
NPI 1225289903
$9,190.13
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $2,829 · 2021: $1,233 · 2022: $3,967 · 2023: $234 · 2024: $164 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,282.14 | 2019-2023 | Teligen |
| Stryker Corporation | $546.19 | 2019-2025 | Mako, Variax, N/A |
| Depuy Synthes Products, INC. | $395.00 | 2020 | |
| Globus Medical, INC. | $286.67 | 2021-2025 | Excelsiusgps Robotic Navigation System, Reline |
| Si-Bone, INC. | $156.81 | 2019-2021 | |
| Relievant Medsystems, INC. | $111.03 | 2023 | Intracept |
| Expanding Innovations, INC. | $93.49 | 2021 | |
| Depuy Synthes Sales INC. | $62.35 | 2019-2020 | |
| Acumed LLC | $59.82 | 2022 | |
| Ethicon US, LLC | $54.33 | 2019-2021 | |
| Smith+Nephew, INC. | $49.97 | 2022 | |
| Pfizer INC. | $41.36 | 2020-2022 | |
| Eclipse Technology Solutions INC. | $20.49 | 2024 | |
| Abbott Laboratories | $17.02 | 2019 | |
| Misonix INC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Greenleaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.